Bio2Business: Company Profile Header

Eurocine Vaccines AB

Eurocine Vaccines is a development company in the highly intense vaccine area, bridging the gap between innovation and market.
Through its portfolio strategy, innovative vaccine candidates are given the opportunity to reach the market quicker, while investors are offered risk diversification with a big future leverage. These candidates are later licensed to partners for commercialization.

The company is in the possession of its own technology platform, Endocine, which has been tested in four extensive clinical studies with over 400 subjects.

Listed at Spotlight Stock Market, XSAT, Eurocine Vaccines, EUCI, today operates at the heart of the bio-scientific cluster of Karolinska Institutet, Solna, Sweden and has attracted several internationally merited vaccine specialists to its board.

Meet the Team

Dr. Hans Arwidsson
Dr. Hans Arwidsson
CEO

Build a fruitful relationship in BioTech – A case of how to create a successful outsourcing partnership between a vaccine developer and a CDMO, Eurocine Vaccines,and Biovian

Dr. Hans Arwidsson, CEO, Eurocine Vaccines AB
Dr. Magnus Gustafsson, Head of Global Business Development, Biovian